These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28128037)

  • 41. Multicenter Study Assessing Physician Recommendations Regarding the Continuation of Aspirin and/or NSAIDs Prior to Gastrointestinal Endoscopy.
    Feuerstein JD; Tapper EB; Belkin E; Lewandowski JJ; Singla A; Sethi S; Sheth SG; Sawheny M
    Dig Dis Sci; 2015 Nov; 60(11):3234-41. PubMed ID: 26123839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
    Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
    N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group.
    Ann Neurol; 1997 Dec; 42(6):857-65. PubMed ID: 9403477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gender differences in the primary prevention of stroke with aspirin.
    Adelman EE; Lisabeth L; Brown DL
    Womens Health (Lond); 2011 May; 7(3):341-52; quiz 352-3. PubMed ID: 21612354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Head Position in the Early Phase of Acute Ischemic Stroke: An International Survey of Current Practice.
    Muñoz Venturelli P; Olavarría V; González F; Brunser A; Lavados P; Arima H; Anderson CS
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1564-9. PubMed ID: 25910872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FPIN's clinical inquiries. Aspirin in patients with acute ischemic stroke.
    Park MK; Smith PC; Wanserski G; Neher JO
    Am Fam Physician; 2009 Feb; 79(3):226-7. PubMed ID: 19202970
    [No Abstract]   [Full Text] [Related]  

  • 47. Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
    Lip GY; Connolly S; Yusuf S; Shestakovska O; Flaker G; Hart R; Lanas F; Xavier D; Eikelboom J;
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):31-8. PubMed ID: 23390125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prescribing patterns of antithrombotic agents for prevention of recurrent ischemic stroke.
    Po HL; Lin YJ; Hseuh IH
    Acta Neurol Taiwan; 2009 Jun; 18(2):98-103. PubMed ID: 19673361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Canadian Primary Care Physicians' Attitudes Toward Understanding Clinical Practice Guidelines for Diabetes Screening.
    Alexander PE; Li SA; Tonelli M; Guyatt G
    Can J Diabetes; 2016 Dec; 40(6):580-585. PubMed ID: 27590082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS).
    Diener HC; Easton JD; Granger CB; Cronin L; Duffy C; Cotton D; Brueckmann M; Sacco RL;
    Int J Stroke; 2015 Dec; 10(8):1309-12. PubMed ID: 26420134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiplatelets and stroke outcomes: state of the science.
    Meyer D
    Crit Care Nurs Clin North Am; 2009 Dec; 21(4):517-28. PubMed ID: 19951767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Community physicians' knowledge of secondary prevention after ischemic stroke: a questionnaire survey in Shanxi Province, China.
    Chen C; Qiao X; Kang H; Ding L; Bai L; Wang J
    BMC Med Educ; 2015 Nov; 15():197. PubMed ID: 26530114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey.
    Haugaa KH; Tilz R; Boveda S; Dobreanu D; Sciaraffia E; Mansourati J; Papiashvili G; Dagres N
    Europace; 2017 Apr; 19(4):660-664. PubMed ID: 28431077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [New form of a acetylsalicylic acid in the secondary prevention of ischemic stroke].
    Shepankevich LA; Vostrikova EB; Pilipenko PI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(4):92-4. PubMed ID: 23814825
    [No Abstract]   [Full Text] [Related]  

  • 56. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
    Jamieson DG; Parekh A; Ezekowitz MD
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rationale and design of the PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage (PICASSO) study: A randomized controlled trial.
    Hong KS; Kim BJ; Lee JY; Kwon SU;
    Int J Stroke; 2015 Oct; 10(7):1153-8. PubMed ID: 26044566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study.
    Huang Y; Cheng Y; Wu J; Li Y; Xu E; Hong Z; Li Z; Zhang W; Ding M; Gao X; Fan D; Zeng J; Wong K; Lu C; Xiao J; Yao C;
    Lancet Neurol; 2008 Jun; 7(6):494-9. PubMed ID: 18456558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prevention of recurrent ischemic stroke: recent clinical trial results].
    Mohr JP
    Neurologia; 2002; 17(7):378-82. PubMed ID: 12236957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events.
    Ringleb PA; Bhatt DL; Hirsch AT; Topol EJ; Hacke W;
    Stroke; 2004 Feb; 35(2):528-32. PubMed ID: 14739421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.